Literature DB >> 10713887

Detection of mutations in mismatch repair genes in Portuguese families with hereditary non-polyposis colorectal cancer (HNPCC) by a multi-method approach.

P Fidalgo1, M R Almeida, S West, C Gaspar, L Maia, J Wijnen, C Albuquerque, A Curtis, M Cravo, R Fodde, C N Leitao, J Burn.   

Abstract

Mutation searching was performed in the hMSH2 and hMLH1 genes in 20 Portuguese families representing 124 registered affected individuals. Of the 20, 16 fulfilled the classic 'Amsterdam' criteria for HNPCC, whereas the remaining four families satisfied a modified set of criteria. These criteria required a CRC diagnosed before age 50 years and cancers diagnosed in two other relatives within the HNPCC spectrum. A multi-method approach was performed using the protein truncation test (PTT), single strand conformation polymorphism (SSCP) with two different sets of conditions, heteroduplex analysis (HA) and denaturing gradient gel electrophoresis (DGGE). Putative phenotype-genotype correlations were also explored. Ten different germline mutations were identified. Six of these were found in hMLH1 in seven families and four in hMSH2 in four families. SSCP and DGGE had the highest diagnostic yields with the percentage of variants detected above 67% and together HA and PTT had the lowest. No single technique detected all variants. Trends for the absence of extracolonic manifestations were observed in families carrying hMLH1 germline mutations (four of seven in hMLH1 vs one of four in hMSH2). Most of the families with rectal cancer were associated with hMLH1 (six of seven in hMLH1 vs two of four in hMSH2). A multi-technique approach is necessary to identify a high percentage of germline mutations. Seven novel mutations were found in this Portuguese population.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10713887     DOI: 10.1038/sj.ejhg.5200393

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  10 in total

1.  An MLH1 mutation links BACH1/FANCJ to colon cancer, signaling, and insight toward directed therapy.

Authors:  Jenny Xie; Shawna Guillemette; Min Peng; Candace Gilbert; Andrew Buermeyer; Sharon B Cantor
Journal:  Cancer Prev Res (Phila)       Date:  2010-10-26

2.  The germline MLH1 K618A variant and susceptibility to Lynch syndrome-associated tumors.

Authors:  Fabiola Medeiros; Noralane M Lindor; Fergus J Couch; W Edward Highsmith
Journal:  J Mol Diagn       Date:  2012-03-13       Impact factor: 5.568

3.  Recurrent germline mutation in MSH2 arises frequently de novo.

Authors:  D C Desai; J C Lockman; R B Chadwick; X Gao; A Percesepe; D G Evans; M Miyaki; S T Yuen; P Radice; E R Maher; F A Wright; A de La Chapelle
Journal:  J Med Genet       Date:  2000-09       Impact factor: 6.318

4.  The phenotypic expression of three MSH2 mutations in large Newfoundland families with Lynch syndrome.

Authors:  Susan Stuckless; Patrick S Parfrey; Michael O Woods; Janet Cox; G William Fitzgerald; Jane S Green; Roger C Green
Journal:  Fam Cancer       Date:  2007       Impact factor: 2.375

5.  Two novel mutations in hMLH1 gene in Iranian hereditary non-polyposis colorectal cancer patients.

Authors:  Somayeh Shahmoradi; Ali Bidmeshkipour; Ahmad Salamian; Mohammad Hasan Emami; Zahra Kazemi; Mansoor Salehi
Journal:  Fam Cancer       Date:  2012-03       Impact factor: 2.375

6.  Pathogenicity of missense and splice site mutations in hMSH2 and hMLH1 mismatch repair genes: implications for genetic testing.

Authors:  M Cravo; A J Afonso; P Lage; C Albuquerque; L Maia; C Lacerda; P Fidalgo; P Chaves; C Cruz; C Nobre-Leitão
Journal:  Gut       Date:  2002-03       Impact factor: 23.059

7.  Assay validation for identification of hereditary nonpolyposis colon cancer-causing mutations in mismatch repair genes MLH1, MSH2, and MSH6.

Authors:  Madhuri Hegde; Maria Blazo; Belinda Chong; Tom Prior; Carolyn Richards
Journal:  J Mol Diagn       Date:  2005-10       Impact factor: 5.568

8.  Clinical characteristics and diagnosis of patients with hereditary nonpolyposis colorectal cancer.

Authors:  San-Jun Cai; Ye Xu; Guo-Xiang Cai; Peng Lian; Zu-Qing Guan; Shan-Jing Mo; Meng-Hong Sun; Qi Cai; Da-Ren Shi
Journal:  World J Gastroenterol       Date:  2003-02       Impact factor: 5.742

9.  Identification of novel pathogenic MSH2 mutation and new DNA repair genes variants: investigation of a Tunisian Lynch syndrome family with discordant twins.

Authors:  Amira Jaballah-Gabteni; Haifa Tounsi; Maria Kabbage; Yosr Hamdi; Sahar Elouej; Ines Ben Ayed; Mouna Medhioub; Moufida Mahmoudi; Hamza Dallali; Hamza Yaiche; Nadia Ben Jemii; Afifa Maaloul; Najla Mezghani; Sonia Abdelhak; Lamine Hamzaoui; Mousaddak Azzouz; Samir Boubaker
Journal:  J Transl Med       Date:  2019-06-27       Impact factor: 5.531

10.  Prevalence of pathological germline mutations of hMLH1 and hMSH2 genes in colorectal cancer.

Authors:  Dandan Li; Fulan Hu; Fan Wang; Binbin Cui; Xinshu Dong; Wencui Zhang; Chunqing Lin; Xia Li; Da Wang; Yashuang Zhao
Journal:  PLoS One       Date:  2013-03-19       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.